Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-Coated vs Conventional Balloons for Side Branch of Coronary Bifurcation Lesions
jRCTs052200077Active, not recruiting
- Sponsor
- Nipro Corporation
- Start
- Nov 2020
- Countries
- 1
01
Overview
Randomised trial in coronary arteriosclerosis (2 arms), sponsored by Nipro Corporation. Primary endpoint: Side branch restenosis rate by QCA at 9 months. Started Nov 2020; status: active, not recruiting.
02
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on jRCTs052200077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs052200077.